cm10

CM10 is an aldehyde dehydrogenase 1A family(ALDH1A) inhibitor.

CM101 is an anti-pathogenic angiogenic polysaccharide derived from Group B Streptococcus. It inhibits inflammatory angiogenesis, accelerates wound healing in mouse models, and reduces scar formation post-spinal cord injury. Additionally, CM101 rapidly induces tumor neovascular inflammation, promotes inflammatory cell infiltration, suppresses tumor growth, and induces tumor apoptosis (apoptosis).

UCM-1306 is a potent and orally active allosteric modulator (PAM) of the human dopamine D1 receptor. It increases the maximal effect of endogenous dopamine (DA) in both human and mouse D1 receptors. UCM-1306 could improve motor symptoms and address key comorbid cognitive impairment associated with long-term Parkinson's disease (PD).

CM-10-18 is a potent inhibitor of ER α-glucosidase, demonstrating superior in vitro antiviral activity against representative viruses from four viral families causing hemorrhagic fever, and efficiently protecting against the lethality of dengue virus infection in mice.

Nebokitug is a humanized IgG1κ antibody targeting CCL24, with HumanIgG1kappa, Isotype Control serving as its corresponding isotype control.